NO20024737L - Farmasöytiske preparater og fremstilling derav - Google Patents

Farmasöytiske preparater og fremstilling derav

Info

Publication number
NO20024737L
NO20024737L NO20024737A NO20024737A NO20024737L NO 20024737 L NO20024737 L NO 20024737L NO 20024737 A NO20024737 A NO 20024737A NO 20024737 A NO20024737 A NO 20024737A NO 20024737 L NO20024737 L NO 20024737L
Authority
NO
Norway
Prior art keywords
particles
emulsion
preparation
pharmaceutical preparations
active substance
Prior art date
Application number
NO20024737A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024737D0 (no
Inventor
John Nicholas Staniforth
Michael John Tobyn
Cheryl Julia Clinch
Robert Price
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9889294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20024737(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vectura Ltd filed Critical Vectura Ltd
Publication of NO20024737D0 publication Critical patent/NO20024737D0/no
Publication of NO20024737L publication Critical patent/NO20024737L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Colloid Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20024737A 2000-04-05 2002-10-02 Farmasöytiske preparater og fremstilling derav NO20024737L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0008411.1A GB0008411D0 (en) 2000-04-05 2000-04-05 Pharmaceutical preparations and their manufacture
PCT/GB2001/001562 WO2001074332A1 (en) 2000-04-05 2001-04-05 Pharmaceutical preparations and their manufacture

Publications (2)

Publication Number Publication Date
NO20024737D0 NO20024737D0 (no) 2002-10-02
NO20024737L true NO20024737L (no) 2002-11-18

Family

ID=9889294

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024737A NO20024737L (no) 2000-04-05 2002-10-02 Farmasöytiske preparater og fremstilling derav

Country Status (22)

Country Link
US (2) US20030157182A1 (de)
EP (1) EP1267833B1 (de)
JP (1) JP2003528907A (de)
KR (1) KR20030011816A (de)
CN (1) CN1420764A (de)
AT (1) ATE269057T1 (de)
AU (1) AU4440601A (de)
BR (1) BR0109802A (de)
CA (1) CA2404367A1 (de)
DE (1) DE60103865T2 (de)
DK (1) DK1267833T3 (de)
ES (1) ES2218402T3 (de)
GB (1) GB0008411D0 (de)
HU (1) HUP0300334A3 (de)
IL (1) IL152074A0 (de)
MX (1) MXPA02009797A (de)
NO (1) NO20024737L (de)
PL (1) PL357808A1 (de)
PT (1) PT1267833E (de)
TR (1) TR200401567T4 (de)
WO (1) WO2001074332A1 (de)
ZA (1) ZA200207508B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5154078B2 (ja) * 2003-02-21 2013-02-27 ザ ユニヴァーシティ オブ バース 粒子の製造プロセス
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
US20070026073A1 (en) * 2005-07-28 2007-02-01 Doney John A Amorphous efavirenz and the production thereof
JP2007326083A (ja) * 2006-06-09 2007-12-20 Fujifilm Corp 固体微粒子及びその製造方法
US20080085315A1 (en) * 2006-10-10 2008-04-10 John Alfred Doney Amorphous ezetimibe and the production thereof
KR101398247B1 (ko) * 2006-11-14 2014-05-22 바스프 에스이 초미세 코어/쉘 입자의 미니유현탁액 또는 현탁액의 제조 방법
US20080152717A1 (en) * 2006-12-14 2008-06-26 Isp Investments, Inc. Amorphous valsartan and the production thereof
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
JP5508859B2 (ja) * 2007-01-26 2014-06-04 アイエスピー インヴェストメンツ インコーポレイテッド 噴霧乾燥製品を製造するための調剤処理方法
WO2008092046A2 (en) * 2007-01-26 2008-07-31 Isp Investments Inc. Amorphous oxcarbazepine and the production thereof
PL220269B1 (pl) 2008-04-21 2015-09-30 Przedsiębiorstwo Produkcji Farmaceutycznej Hasco Lek Spółka Akcyjna Kompozytowy nośnik leków proszkowych, sposób wytwarzania nośnika leków oraz urządzenie do wytwarzania cząstek nośnika kompozytowego
CA2729644C (en) * 2008-07-18 2018-05-29 Prosonix Limited Process for improving crystallinity
CN102107127B (zh) * 2011-01-11 2015-04-22 西安蓝晓科技新材料股份有限公司 一种粉体造粒技术
CN103764167A (zh) * 2011-07-15 2014-04-30 尤法玛有限公司 包含抗酸剂、麻醉剂以及含二氧化硅和二氧化钛的无机基质的口服组合物
PT107433B (pt) * 2014-01-28 2018-12-04 Hovione Farm S A Processo de redução e controlo do tamanho de partícula
WO2018087870A1 (ja) * 2016-11-10 2018-05-17 日本たばこ産業株式会社 球状の粉末凝集体及びその製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
FR2694895B1 (fr) * 1992-08-20 1994-11-10 Coletica Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification.
EP2283821A1 (de) * 1993-11-19 2011-02-16 Alkermes, Inc. Herstellung biodegradierbarer Mikroteilchen, die ein biologisch aktives Mittel enthalten
US6214331B1 (en) * 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
DE19617085A1 (de) * 1996-04-29 1997-10-30 Bayer Ag Verfahren zur Herstellung von feinstteiligen Kristallisationsprodukten
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US6150505A (en) 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions

Also Published As

Publication number Publication date
PT1267833E (pt) 2004-11-30
US20100015234A1 (en) 2010-01-21
US20030157182A1 (en) 2003-08-21
ES2218402T3 (es) 2004-11-16
GB0008411D0 (en) 2000-05-24
EP1267833B1 (de) 2004-06-16
IL152074A0 (en) 2003-05-29
HUP0300334A2 (hu) 2003-09-29
TR200401567T4 (tr) 2004-08-23
DK1267833T3 (da) 2004-07-19
ATE269057T1 (de) 2004-07-15
CN1420764A (zh) 2003-05-28
EP1267833A1 (de) 2003-01-02
ZA200207508B (en) 2003-09-19
MXPA02009797A (es) 2004-09-13
WO2001074332A1 (en) 2001-10-11
DE60103865D1 (de) 2004-07-22
JP2003528907A (ja) 2003-09-30
DE60103865T2 (de) 2004-10-28
AU4440601A (en) 2001-10-15
KR20030011816A (ko) 2003-02-11
HUP0300334A3 (en) 2005-04-28
BR0109802A (pt) 2003-01-21
PL357808A1 (en) 2004-07-26
CA2404367A1 (en) 2001-10-11
NO20024737D0 (no) 2002-10-02

Similar Documents

Publication Publication Date Title
NO20024737D0 (no) Farmasöytiske preparater og fremstilling derav
CY1112338T1 (el) Μεθοδος παρασκευης σωματιδιων για χρηση σε φαρμακευτικη συνθεση
DK0737065T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske doseringsformer
DK1283700T3 (da) Farmaceutiske sustained release-præparater til parenteral administration af biologisk aktive hydrofile forbindelser
DK0737064T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske doseringsformer af hydrofobe stoffer
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
NL930038I2 (nl) Farmaceutische preparaten, welke een invloed op demaagzuurafscheiding bezitten en ten minste een qu anidinothiazoolderivaat als werkzame stof bevattenalsmede de voor gebruik in dergelijke preparaten geschikte quanidinothiazoolderivaten.
DK0762896T3 (da) Tocopherol-sammensætninger til levering af biologisk aktive stoffer
SI1051174T1 (sl) Gastroprotektirane omeprazolne mikrogranule, postopek za pridobivanje le-teh in farmacevtski pripravki
MXPA05013278A (es) Composiciones farmaceuticas que comprenden compuestos activos de vitamina d.
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
DK0973506T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske doseringsformer
ATE291908T1 (de) Ibuprofen-wirkstoffzubereitung
AU2003293593A1 (en) Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration
AU5812800A (en) Pharmaceutical preparation
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
WO2000003724A1 (en) Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
WO2003041656A3 (en) Soluble drug extended release system
WO2002070014A8 (en) Compositions comprising an o/w emulsion containing conjugated linoleic acid
FR2803848B1 (fr) Nouveaux derives de benzenesulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PT1178787E (pt) Composicoes farmacologicas para administracao por via oral de floroglucinol e suas preparacoes
ATE294181T1 (de) (3,4-a:3,4-c)carbazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
NO20013878L (no) (1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende de samme
EP1273301A3 (de) Pharmazeutische Zubereitungen, Wirkstoffe enthaltend, die sich für unerlaubte Verabreichung bieten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application